Tower Research Capital LLC (Trc) Unity Biotechnology, Inc. Transaction History

Tower Research Capital LLC (Trc)

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$0.4 - $4.27 $6,759 - $72,154	-16,898 Reduced 99.76%	41 $0
Q2 2022 Aug 15, 2022	BUY	$0.56 - $1.29 $8,734 - $20,121	15,598 Added 1163.16%	16,939 $10,000
Q1 2022 May 12, 2022	SELL	$0.72 - $1.86 $4,093 - $10,574	-5,685 Reduced 80.91%	1,341 $2,000
Q4 2021 Feb 14, 2022	SELL	$1.3 - $3.17 $12,010 - $29,287	-9,239 Reduced 56.8%	7,026 $10,000
Q3 2021 Nov 15, 2021	BUY	$2.91 - $4.5 $35,263 - $54,531	12,118 Added 292.21%	16,265 $48,000
Q2 2021 Aug 16, 2021	BUY	$4.15 - $6.3 $1,195 - $1,814	288 Added 7.46%	4,147 $19,000
Q1 2021 May 17, 2021	SELL	$5.51 - $9.42 $8,242 - $14,092	-1,496 Reduced 27.94%	3,859 $23,000
Q4 2020 Feb 16, 2021	SELL	$3.42 - $6.36 $102,056 - $189,788	-29,841 Reduced 84.79%	5,355 $28,000
Q3 2020 Nov 16, 2020	BUY	$2.94 - $12.43 $86,441 - $365,466	29,402 Added 507.46%	35,196 $121,000
Q2 2020 Aug 13, 2020	BUY	$5.28 - $9.67 $24,266 - $44,443	4,596 Added 383.64%	5,794 $51,000
Q1 2020 May 15, 2020	SELL	$5.0 - $7.6 $25,370 - $38,562	-5,074 Reduced 80.9%	1,198 $7,000
Q4 2019 Feb 07, 2020	SELL	$5.99 - $8.38 $6,798 - $9,511	-1,135 Reduced 15.32%	6,272 $45,000
Q3 2019 Nov 05, 2019	BUY	$5.62 - $9.63 $41,627 - $71,329	7,407 New	7,407 $45,000
Q2 2019 Aug 13, 2019	SELL	$7.59 - $10.21 $49,737 - $66,906	-6,553 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$7.65 - $16.66 $50,130 - $109,172	6,553 New	6,553 $53,000
Q4 2018 Feb 14, 2019	SELL	$10.76 - $17.25 $10,609 - $17,008	-986 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$14.34 - $22.97 $14,139 - $22,648	986 New	986 $16,000

4.41M

Ticker UBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,036,200
Market Cap $16.1M
Description
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.